Dr Nirmala Pathmanathan

Clinical Associate Professor
Westmead Clinical School


Map

Selected grants

2017

  • Using EHR data to drive translation of evidence into practice and improve cancer care provided by teams and individuals; Shaw T, Pathmanathan N; Cancer Institute NSW/Innovations in Cancer Control.

2016

  • A pilot study to develop novel targeted treatments and personalized tests for triple negative breast cancer; Graham J, Dinh P, Clarke C, Harnett P, Pathmanathan N; National Breast Cancer Foundation/Pilot Study Grants.

2010

  • Investigating the role of microRNAs in breast cancer progression; Soon P, Balleine R, Clarke C, Pathmanathan N; National Breast Cancer Foundation/Pilot Study Grants.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Jacklyn, G., Morrell, S., McGeechan, K., Houssami, N., Irwig, L., Pathmanathan, N., Barratt, A. (2018). Carcinoma in situ of the breast in New South Wales, Australia: Current status and trends over the last 40 year. Breast, 37, 170-178. [More Information]
  • Pathmanathan, N., Geng, J., Li, W., Nie, X., Veloso, J., Wang, J., Hill, J., McCloud, P., Bilous, M. (2017). Human epidermal growth factor receptor 2 status of gastric cancer patients in Asia: results from a large, multicountry study. Asia-Pacific Journal of Clinical Oncology, 13(3), 249-260. [More Information]
  • Pathmanathan, N., Geng, J., Li, W., Nie, X., Veloso, J., Hill, J., McCloud, P., Bilous, M. (2016). Human epidermal growth factor receptor 2 status of breast cancer patients in Asia: Results from a large, multicountry study. Asia-Pacific Journal of Clinical Oncology, 12(4), 369-379. [More Information]
  • Pathmanathan, N., Renthawa, J., French, J., Elder, E., Hall, G., Mahajan, H., Teh, C., Bilous, M. (2014). Intraoperative sentinel lymph node assessment in breast cancer: a comparison of rapid diagnostic method based on CK19 mRNA expression and imprint cytology. ANZ Journal of Surgery, 84(10), 730-734. [More Information]
  • Pathmanathan, N., Balleine, R., Jayasinghe, U., Stalgis-Bilinski, K., Provan, P., Byth Wilson, K., Bilous, M., Salisbury, E., Boyages, J. (2014). The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer. Journal of Clinical Pathology, 67(3), 222-228. [More Information]
  • Pathmanathan, N., Balleine, R. (2013). Ki67 and proliferation in breast cancer. Journal of Clinical Pathology, 66(6), 512-516. [More Information]
  • Pathmanathan, N., Provan, P., Mahajan, H., Hall, G., Byth Wilson, K., Bilous, M., Balleine, R. (2012). Characteristics of HER2-positive breast cancer diagnosed following the introduction of universal HER2 testing. The Breast, 21(6), 724-729. [More Information]
  • Pathmanathan, N., Bilous, M. (2012). HER2 testing in breast cancer: An overview of current techniques and recent developments. Pathology, 44(7), 587-595. [More Information]
  • Pathmanathan, N., Albertini, A., Provan, P., Milliken, J., Salisbury, E., Bilous, M., Byth Wilson, K., Balleine, R. (2010). Diagnostic evaluation of papillary lesions of the breast on core biopsy. Modern Pathology, 23(7), 1021-1028. [More Information]
  • Balleine, R., Provan, P., Pupo, G., Pathmanathan, N., Cummings, M., Farshid, G., Salisbury, E., Bilous, M., Byth Wilson, K., kConFab Investigators., Mann, G. (2010). Familial Concordance of Breast Cancer Pathology as an Indicator of Genotype in Multiple-Case Families. Genes Chromosomes and Cancer, 49(12), 1082-1094. [More Information]
  • Murali, R., Salisbury, E., Pathmanathan, N. (2006). Histiocytoid change in breast carcinoma - A report of 3 cases with an unusual cytomorphologic pattern of apocrine change. Acta Cytologica, 50(5), 548-552. [More Information]
  • Pathmanathan, N., Jones, W., Salisbury, E., Bilous, M. (2006). Intraoperative imprint cytology of sentinel lymph nodes in breast cancer: Initial experience and lessons learnt in establishing a new practice. Pathology, 38(4), 321-327. [More Information]
  • Thiagalingam, A., Pouliopoulos, J., Barry, M., Salisbury, E., Pathmanathan, N., Boyd, A., Ross, D., Kovoor, P. (2005). A thermochromic dispersive electrode can measure the underlying skin temperature and prevent burns during radiofrequency ablation. Journal of Cardiovascular Electrophysiology, 16(7), 781-788. [More Information]
  • Pathmanathan, N., Murali, R. (2003). Composite phaeochromocytoma with intra-tumoural metastatic squamous cell carcinoma [3]. Pathology, 35(3), 263-265. [More Information]

2018

  • Jacklyn, G., Morrell, S., McGeechan, K., Houssami, N., Irwig, L., Pathmanathan, N., Barratt, A. (2018). Carcinoma in situ of the breast in New South Wales, Australia: Current status and trends over the last 40 year. Breast, 37, 170-178. [More Information]

2017

  • Pathmanathan, N., Geng, J., Li, W., Nie, X., Veloso, J., Wang, J., Hill, J., McCloud, P., Bilous, M. (2017). Human epidermal growth factor receptor 2 status of gastric cancer patients in Asia: results from a large, multicountry study. Asia-Pacific Journal of Clinical Oncology, 13(3), 249-260. [More Information]

2016

  • Pathmanathan, N., Geng, J., Li, W., Nie, X., Veloso, J., Hill, J., McCloud, P., Bilous, M. (2016). Human epidermal growth factor receptor 2 status of breast cancer patients in Asia: Results from a large, multicountry study. Asia-Pacific Journal of Clinical Oncology, 12(4), 369-379. [More Information]

2014

  • Pathmanathan, N., Renthawa, J., French, J., Elder, E., Hall, G., Mahajan, H., Teh, C., Bilous, M. (2014). Intraoperative sentinel lymph node assessment in breast cancer: a comparison of rapid diagnostic method based on CK19 mRNA expression and imprint cytology. ANZ Journal of Surgery, 84(10), 730-734. [More Information]
  • Pathmanathan, N., Balleine, R., Jayasinghe, U., Stalgis-Bilinski, K., Provan, P., Byth Wilson, K., Bilous, M., Salisbury, E., Boyages, J. (2014). The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer. Journal of Clinical Pathology, 67(3), 222-228. [More Information]

2013

  • Pathmanathan, N., Balleine, R. (2013). Ki67 and proliferation in breast cancer. Journal of Clinical Pathology, 66(6), 512-516. [More Information]

2012

  • Pathmanathan, N., Provan, P., Mahajan, H., Hall, G., Byth Wilson, K., Bilous, M., Balleine, R. (2012). Characteristics of HER2-positive breast cancer diagnosed following the introduction of universal HER2 testing. The Breast, 21(6), 724-729. [More Information]
  • Pathmanathan, N., Bilous, M. (2012). HER2 testing in breast cancer: An overview of current techniques and recent developments. Pathology, 44(7), 587-595. [More Information]

2010

  • Pathmanathan, N., Albertini, A., Provan, P., Milliken, J., Salisbury, E., Bilous, M., Byth Wilson, K., Balleine, R. (2010). Diagnostic evaluation of papillary lesions of the breast on core biopsy. Modern Pathology, 23(7), 1021-1028. [More Information]
  • Balleine, R., Provan, P., Pupo, G., Pathmanathan, N., Cummings, M., Farshid, G., Salisbury, E., Bilous, M., Byth Wilson, K., kConFab Investigators., Mann, G. (2010). Familial Concordance of Breast Cancer Pathology as an Indicator of Genotype in Multiple-Case Families. Genes Chromosomes and Cancer, 49(12), 1082-1094. [More Information]

2006

  • Murali, R., Salisbury, E., Pathmanathan, N. (2006). Histiocytoid change in breast carcinoma - A report of 3 cases with an unusual cytomorphologic pattern of apocrine change. Acta Cytologica, 50(5), 548-552. [More Information]
  • Pathmanathan, N., Jones, W., Salisbury, E., Bilous, M. (2006). Intraoperative imprint cytology of sentinel lymph nodes in breast cancer: Initial experience and lessons learnt in establishing a new practice. Pathology, 38(4), 321-327. [More Information]

2005

  • Thiagalingam, A., Pouliopoulos, J., Barry, M., Salisbury, E., Pathmanathan, N., Boyd, A., Ross, D., Kovoor, P. (2005). A thermochromic dispersive electrode can measure the underlying skin temperature and prevent burns during radiofrequency ablation. Journal of Cardiovascular Electrophysiology, 16(7), 781-788. [More Information]

2003

  • Pathmanathan, N., Murali, R. (2003). Composite phaeochromocytoma with intra-tumoural metastatic squamous cell carcinoma [3]. Pathology, 35(3), 263-265. [More Information]

To update your profile click here. For support on your academic profile contact .